Ironwood Pharmaceuticals (IRWD)
(Delayed Data from NSDQ)
$4.98 USD
+0.29 (6.18%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $4.98 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
C Value C Growth D Momentum D VGM
Brokerage Reports
Ironwood Pharmaceuticals, Inc. [IRWD]
Reports for Purchase
Showing records 101 - 120 ( 1026 total )
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended November 15
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended November 8
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
3Q19 Financials Reported; Moderately Better Revenue Growth; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Biotechnology - Recent Drug Launch Weekly Retail Sales Tracker - Week Ended October 25
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Biotechnology - Recent Drug Launch Weekly Retail Sales Tracker - Week Ended October 18
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
We are dropping coverage due to realignment of analyst resources
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Biotechnology - Recent Drug Launch Weekly Retail Sales Tracker - Week Ended August 23
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Retail Prescription Sales Tracker - Constipation Drugs
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Biotechnology - Recent Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Retail Prescription Sales Tracker - Constipation Drugs
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Biotechnology - Recent Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Retail Prescription Sales Tracker - Constipation Drugs
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
2Q19 Financial Results Reported; Revenue Guidance Maintained; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R